Please enable JavaScript to continue using this application.

Compare $CMPX vs $CUE | Chartloom

Compare

$CMPX vs $CUE

Compass Therapeutics Inc. · Cue Biopharma Inc

CMPX

Compass Therapeutics Inc.

CUE

Cue Biopharma Inc

Compare $CMPX vs $CUE

Comparing Compass Therapeutics Inc. and Cue Biopharma Inc

CMPXCompass Therapeutics Inc.

CUECue Biopharma Inc

CMPXCompass Therapeutics Inc.

Market cap

$179M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.51x

Rev growth (TTM)

—

YTD performance

-80.8%

52W performance

-74.5%

FCF yield

-31.5%

CUECue Biopharma Inc

Market cap

$112M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

354.4%

YTD performance

173.6%

52W performance

7.5%

FCF yield

-44.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CMPX

CUE

Detailed metrics comparison

CMPX

Compass Therapeutics Inc.

CUE

Cue Biopharma Inc

Market Cap

CMPX$179M

CUE$112M

Enterprise Value

CMPX$143M

CUE$95M

Price

CMPX$0.99

CUE$27.66

P/E Ratio

CMPXN/A

CUEN/A

P/S Ratio

CMPX0.00x

CUE2.98x

EV/Sales

CMPX0.00x

CUE2.51x

EV/EBITDA

CMPX0.00x

CUE0.00x

P/B Ratio

CMPX0.93x

CUE80.41x

P/FCF Ratio

CMPXN/A

CUEN/A

EV/FCF

CMPX-2.54x

CUE-1.89x

PEG Ratio

CMPXN/A

CUEN/A

Forward P/E (NTM)

CMPXN/A

CUEN/A

Forward P/S (NTM)

CMPX1.51x

CUEN/A

Revenue (TTM)

CMPX$0

CUE$38M

Revenue Growth (YoY)

CMPXN/A

CUE354.4%

Forward Rev Growth

CMPX397.5%

CUE-38.2%

Gross Margin (TTM)

CMPX0.0%

CUE0.0%

Operating Margin (TTM)

CMPX0.0%

CUE0.0%

EBITDA Margin (TTM)

CMPX0.0%

CUE-258.4%

Net Margin (TTM)

CMPX0.0%

CUE-435.8%

FCF Margin (TTM)

CMPXN/A

CUE-133.2%

Net Income (TTM)

CMPX$-30M

CUE$-164M

FCF (TTM)

CMPX$-56M

CUE$-50M

EPS (TTM)

CMPX$0.00

CUE-$25.88

ROE (TTM)

CMPX-2994.0%

CUE-103219.0%

ROA (TTM)

CMPX-2635.0%

CUE-48467.0%

ROIC (TTM)

CMPX-2994.0%

CUE-100612.0%

Cash

CMPX$35M

CUE$17M

Debt

CMPX$0

CUE$0

Net Cash/Debt

CMPX$35M

CUE$17M

Current Ratio (TTM)

CMPX11.22x

CUE1.25x

Quick Ratio (TTM)

CMPX11.15x

CUE1.16x

Debt/Equity (TTM)

CMPX0.00x

CUE0.00x

Debt/Assets (TTM)

CMPX0.0%

CUE0.0%

Interest Coverage (TTM)

CMPXN/A

CUEN/A

Net Debt/EBITDA (TTM)

CMPX0.00x

CUE0.00x

Beta

CMPX1.07

CUE2.84

52W Performance

CMPX-74.5%

CUE7.5%

YTD Performance

CMPX-80.8%

CUE173.6%

% from 52W High

CMPX-85.6%

CUE-39.2%

% from 52W Low

CMPX19.7%

CUE456.4%

Asset Turnover (TTM)

CMPX0.00x

CUE1.11x

FCF Yield (TTM)

CMPX-31.5%

CUE-44.8%

Earnings Yield (TTM)

CMPX-16.8%

CUE-146.5%

Dividend Yield (TTM)

CMPXN/A

CUEN/A

Rule of 40

CMPX0.0

CUE221.1

EV/GP/RG

CMPXN/A

CUEN/A

Ticker research

View CMPX research View CUE research

Metric	CMPX Compass Therapeutics Inc.	CUE Cue Biopharma Inc
Market & Valuation
Market Cap	$179M	$112M
Enterprise Value	$143M	$95M
Price	$0.99	$27.66
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	2.98x
EV/Sales	0.00x	2.51x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.93x	80.41x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.54x	-1.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.51x	N/A
Revenue & Growth
Revenue (TTM)	$0	$38M
Revenue Growth (YoY)	N/A	354.4%
Forward Rev Growth	397.5%	-38.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-258.4%
Net Margin (TTM)	0.0%	-435.8%
FCF Margin (TTM)	N/A	-133.2%
Net Income (TTM)	$-30M	$-164M
FCF (TTM)	$-56M	$-50M
EPS (TTM)	$0.00	-$25.88
ROE (TTM)	-2994.0%	-103219.0%
ROA (TTM)	-2635.0%	-48467.0%
ROIC (TTM)	-2994.0%	-100612.0%
Financial Health
Cash	$35M	$17M
Debt	$0	$0
Net Cash/Debt	$35M	$17M
Current Ratio (TTM)	11.22x	1.25x
Quick Ratio (TTM)	11.15x	1.16x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.07	2.84
52W Performance	-74.5%	7.5%
YTD Performance	-80.8%	173.6%
% from 52W High	-85.6%	-39.2%
% from 52W Low	19.7%	456.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.11x
FCF Yield (TTM)	-31.5%	-44.8%
Earnings Yield (TTM)	-16.8%	-146.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	221.1
EV/GP/RG	N/A	N/A
Ticker research	View CMPX research	View CUE research

Valuation

P/S Ratio

CMPX

0.00x

CUE

2.98x

EV/FCF

CMPX

-2.54x

CUE

-1.89x

Growth & revenue

Revenue Growth TTM

CUE

354.4%

Forward Revenue Growth

CMPX

397.5%

CUE

-38.2%

Profitability & performance

Gross Margin

CMPX

0.0%

CUE

0.0%

ROE

CMPX

-2994.0%

CUE

-103219.0%

FCF Yield %

CMPX

-31.5%

CUE

-44.8%

52-Week Performance

CUE

7.5%

CMPX

-74.5%

Detailed metrics comparison

CMPX

Compass Therapeutics Inc.

CUE

Cue Biopharma Inc

Market Cap

CMPX$179M

CUE$112M

Enterprise Value

CMPX$143M

CUE$95M

Price

CMPX$0.99

CUE$27.66

P/E Ratio

CMPXN/A

CUEN/A

P/S Ratio

CMPX0.00x

CUE2.98x

EV/Sales

CMPX0.00x

CUE2.51x

EV/EBITDA

CMPX0.00x

CUE0.00x

P/B Ratio

CMPX0.93x

CUE80.41x

P/FCF Ratio

CMPXN/A

CUEN/A

EV/FCF

CMPX-2.54x

CUE-1.89x

PEG Ratio

CMPXN/A

CUEN/A

Forward P/E (NTM)

CMPXN/A

CUEN/A

Forward P/S (NTM)

CMPX1.51x

CUEN/A

Revenue (TTM)

CMPX$0

CUE$38M

Revenue Growth (YoY)

CMPXN/A

CUE354.4%

Forward Rev Growth

CMPX397.5%

CUE-38.2%

Gross Margin (TTM)

CMPX0.0%

CUE0.0%

Operating Margin (TTM)

CMPX0.0%

CUE0.0%

EBITDA Margin (TTM)

CMPX0.0%

CUE-258.4%

Net Margin (TTM)

CMPX0.0%

CUE-435.8%

FCF Margin (TTM)

CMPXN/A

CUE-133.2%

Net Income (TTM)

CMPX$-30M

CUE$-164M

FCF (TTM)

CMPX$-56M

CUE$-50M

EPS (TTM)

CMPX$0.00

CUE-$25.88

ROE (TTM)

CMPX-2994.0%

CUE-103219.0%

ROA (TTM)

CMPX-2635.0%

CUE-48467.0%

ROIC (TTM)

CMPX-2994.0%

CUE-100612.0%

Cash

CMPX$35M

CUE$17M

Debt

CMPX$0

CUE$0

Net Cash/Debt

CMPX$35M

CUE$17M

Current Ratio (TTM)

CMPX11.22x

CUE1.25x

Quick Ratio (TTM)

CMPX11.15x

CUE1.16x

Debt/Equity (TTM)

CMPX0.00x

CUE0.00x

Debt/Assets (TTM)

CMPX0.0%

CUE0.0%

Interest Coverage (TTM)

CMPXN/A

CUEN/A

Net Debt/EBITDA (TTM)

CMPX0.00x

CUE0.00x

Beta

CMPX1.07

CUE2.84

52W Performance

CMPX-74.5%

CUE7.5%

YTD Performance

CMPX-80.8%

CUE173.6%

% from 52W High

CMPX-85.6%

CUE-39.2%

% from 52W Low

CMPX19.7%

CUE456.4%

Asset Turnover (TTM)

CMPX0.00x

CUE1.11x

FCF Yield (TTM)

CMPX-31.5%

CUE-44.8%

Earnings Yield (TTM)

CMPX-16.8%

CUE-146.5%

Dividend Yield (TTM)

CMPXN/A

CUEN/A

Rule of 40

CMPX0.0

CUE221.1

EV/GP/RG

CMPXN/A

CUEN/A

Ticker research

View CMPX research View CUE research

Metric	CMPX Compass Therapeutics Inc.	CUE Cue Biopharma Inc
Market & Valuation
Market Cap	$179M	$112M
Enterprise Value	$143M	$95M
Price	$0.99	$27.66
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	2.98x
EV/Sales	0.00x	2.51x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.93x	80.41x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.54x	-1.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.51x	N/A
Revenue & Growth
Revenue (TTM)	$0	$38M
Revenue Growth (YoY)	N/A	354.4%
Forward Rev Growth	397.5%	-38.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-258.4%
Net Margin (TTM)	0.0%	-435.8%
FCF Margin (TTM)	N/A	-133.2%
Net Income (TTM)	$-30M	$-164M
FCF (TTM)	$-56M	$-50M
EPS (TTM)	$0.00	-$25.88
ROE (TTM)	-2994.0%	-103219.0%
ROA (TTM)	-2635.0%	-48467.0%
ROIC (TTM)	-2994.0%	-100612.0%
Financial Health
Cash	$35M	$17M
Debt	$0	$0
Net Cash/Debt	$35M	$17M
Current Ratio (TTM)	11.22x	1.25x
Quick Ratio (TTM)	11.15x	1.16x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.07	2.84
52W Performance	-74.5%	7.5%
YTD Performance	-80.8%	173.6%
% from 52W High	-85.6%	-39.2%
% from 52W Low	19.7%	456.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.11x
FCF Yield (TTM)	-31.5%	-44.8%
Earnings Yield (TTM)	-16.8%	-146.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	221.1
EV/GP/RG	N/A	N/A
Ticker research	View CMPX research	View CUE research